HAMANOVÁ, Markéta, Magda CHMELÍKOVÁ, Ivo NENTWICH, Vojtěch THON and Jindřich LOKAJ. Anti-Gal IgM, IgA and IgG Natural Antibodies in Childhood. Immunology Letters. Amsterdam: Elsevier, 2015, vol. 164, No 1, p. 40-43. ISSN 0165-2478. Available from: https://dx.doi.org/10.1016/j.imlet.2015.02.001.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Anti-Gal IgM, IgA and IgG Natural Antibodies in Childhood
Authors HAMANOVÁ, Markéta (203 Czech Republic, belonging to the institution), Magda CHMELÍKOVÁ (203 Czech Republic, belonging to the institution), Ivo NENTWICH (203 Czech Republic), Vojtěch THON (203 Czech Republic, guarantor, belonging to the institution) and Jindřich LOKAJ (203 Czech Republic, belonging to the institution).
Edition Immunology Letters, Amsterdam, Elsevier, 2015, 0165-2478.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30102 Immunology
Country of publisher Netherlands
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 2.483
RIV identification code RIV/00216224:14110/15:00082841
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1016/j.imlet.2015.02.001
UT WoS 000351801500006
Keywords in English Anti-Gal; Childhood; Immunodeficiency; Kinetics; Natural antibodies
Tags EL OK
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 28/8/2015 14:33.
Abstract
The target for the most abundant xenoreactive natural antibodies in humans is the a-Gal epitope. Anti-Gal could provide natural immune defense against pathogens that express the a-Gal epitope. Anti-Gal natural antibodies are usually studied in adult individuals. Data demonstrating the incidence and concentration of anti-Gal natural antibodies in childhood are in short supply and incomplete. In the present study we prospectively quantified anti-Gal IgM, IgA and IgG levels in different age groups of children from delivery to 24 months of age and compared these levels to the level of these antibodies in their respective mothers. Measurement of anti-Gal antibodies may broaden the spectrum of specific antibodies that are available for determination of specific antibody responses in physiological and pathological conditions in children. Plasma was collected from umbilical cord blood of full term newborn, from blood of infants at age 6, 12 and 24 months and from their respective mothers at time of delivery. Quantitative determination of anti-Gal antibodies IgM, IgA and IgG were made with the enzyme immunoassays Human Anti-Alpha Galactosyl IgM ELISA, IgG ELISA and IgA ELISA. Hemagglutination activity was titrated against rabbit erythrocytes. The kinetic processes for the formation of natural antibodies in the first two years of life, in general, compared with the kinetics for the formation of total immunoglobulins IgM, IgA and IgG. There were no detectable anti-Gal IgM and IgA in the cord blood, whereas anti-Gal IgG were found at similar levels in both neonate cord blood and peripheral blood of their respective mothers. When comparing the percentage of natural antibodies in the plasma of children, the level of natural antibodies in children at the age of two years was approximately 37% for IgM, 25% for IgG and 15% for IgA. The titration of antibodies required for agglutination of rabbit red blood cells over the 24 month period followed the same trend observed for the formation of natural antibodies. Our study demonstrates the kinetics of formation of anti-Gal IgM, IgA and IgG natural antibodies in the first two years of life. The relative lack of these antibodies in this period should be taken into account when assessing for humoral immunodeficiencies, particularly with regards to the potential for children to mount an anti-carbohydrate response.
Links
7E08062, research and development projectName: Pathophysiology and Natural Course of Primary Antibody Deficiency (PAD) Syndromes
Investor: Ministry of Education, Youth and Sports of the CR, Pathophysiology and Natural Course of Primary Antibody Deficiency (PAD) Syndromes
PrintDisplayed: 23/7/2024 20:21